Edition:
United Kingdom

Altria Group Inc (MO.N)

MO.N on New York Stock Exchange

64.20USD
2:31pm GMT
Change (% chg)

$0.01 (+0.02%)
Prev Close
$64.19
Open
$64.19
Day's High
$64.34
Day's Low
$64.16
Volume
83,453
Avg. Vol
1,887,696
52-wk High
$77.79
52-wk Low
$60.01

Chart for

About

Altria Group, Inc. is a holding company. The Company's segments include smokeable products, smokeless products and wine. The Company's subsidiaries include Philip Morris USA Inc. (PM USA), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (Middleton), which is engaged in the... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $120,006.40
Shares Outstanding(Mil.): 1,918.57
Dividend: 0.66
Yield (%): 4.22

Financials

  Industry Sector
P/E (TTM): -- 31.85 16.60
EPS (TTM): -- -- --
ROI: -- 37.94 10.66
ROE: -- 40.43 14.30

BRIEF-Altria Reaffirms Full-Year 2018 Earnings Guidance

* ALTRIA PRESENTS AT THE CONSUMER ANALYST GROUP OF NEW YORK CONFERENCE; REAFFIRMS FULL-YEAR 2018 EARNINGS GUIDANCE

1:22pm GMT

BRIEF-Altria Reports Q4 Adjusted Earnings Per Share $0.91

* ALTRIA REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS; PROVIDES 2018 FULL-YEAR EARNINGS GUIDANCE

01 Feb 2018

Philip Morris sees six million U.S. smokers switching to iQOS device if cleared

WASHINGTON Philip Morris International Inc told a U.S. advisory panel on Wednesday that it expects around 6 million smokers to switch completely to its iQOS electronic tobacco device if the company is allowed to claim it is less risky than cigarettes.

25 Jan 2018

UPDATE 2-Philip Morris sees 6 mln U.S. smokers switching to iQOS device if cleared

WASHINGTON, Jan 24 Philip Morris International Inc told a U.S. advisory panel on Wednesday that it expects around 6 million smokers to switch completely to its iQOS electronic tobacco device if the company is allowed to claim it is less risky than cigarettes.

24 Jan 2018

U.S. health advisers weigh risks of novel Philip Morris tobacco device

WASHINGTON, Jan 24 U.S. health advisers on Wednesday began to consider whether Philip Morris International Inc should be allowed to claim its novel electronic tobacco product is less harmful than cigarettes, potentially making it the first such device to carry a reduced risk claim.

24 Jan 2018

U.S. FDA's tobacco stance faces test with Philip Morris iQOS device

WASHINGTON In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc to claim its novel iQOS tobacco device is less harmful than cigarettes.

22 Jan 2018

FDA's tobacco stance faces test with Philip Morris iQOS device

WASHINGTON In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc to claim its novel iQOS tobacco device is less harmful than cigarettes. | Video

22 Jan 2018

FDA's tobacco stance faces test with Philip Morris iQOS device

WASHINGTON In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc to claim its novel iQOS tobacco device is less harmful than cigarettes.

22 Jan 2018

UPDATE 1-U.S. FDA's tobacco stance faces test with Philip Morris iQOS device

WASHINGTON, Jan 22 In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc to claim its novel iQOS tobacco device is less harmful than cigarettes.

22 Jan 2018

UPDATE 2-U.S. FDA releases initial review of Philip Morris' iQOS device

Jan 22 An electronic product made by Philip Morris International Inc that heats rather than burns tobacco contains lower levels of harmful and potentially harmful compounds than cigarettes, a preliminary review by the U.S. Food and Drug Administration (FDA) concluded on Monday.

22 Jan 2018

Earnings vs. Estimates